Free Trial

ImmunoPrecise Antibodies (IPA) Institutional Ownership

ImmunoPrecise Antibodies logo
$0.44 +0.01 (+2.55%)
Closing price 04/17/2025 03:59 PM Eastern
Extended Trading
$0.40 -0.04 (-8.65%)
As of 04/17/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for ImmunoPrecise Antibodies (NASDAQ:IPA)

Current
Institutional Ownership
Percentage
6.70%
Number of
Institutional Buyers
(last 12 months)
2
Total
Institutional Inflows
(last 12 months)
$194.92K
Number of
Institutional Sellers
(last 12 months)
0
Get IPA Insider Trade Alerts

Want to know when executives and insiders are buying or selling ImmunoPrecise Antibodies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IPA Institutional Buying and Selling by Quarter

ImmunoPrecise Antibodies Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2024Ingalls & Snyder LLC1,558,892$996K0.0%+20.3%5.407%
8/9/2024Renaissance Technologies LLC63,910$65K0.0%+70.0%0.243%
1/29/2024Ingalls & Snyder LLC1,281,305$2.19M0.1%+24.6%4.868%
11/13/2023Rathbones Group PLC14,000$26K0.0%N/A0.056%
11/2/2023Ingalls & Snyder LLC1,028,253$1.88M0.1%-3.0%4.105%
8/2/2023Bank of Montreal Can208,110$668K0.0%N/A0.831%
5/9/2023Ingalls & Snyder LLC1,058,035$2.93M0.2%+9.1%4.244%
2/1/2023Bank of Montreal Can240,980$1.25M0.0%+6.0%0.966%
1/31/2023Ingalls & Snyder LLC970,147$5.05M0.3%+0.3%3.891%
11/7/2022Gradient Capital Advisors LLC26,808$107K0.1%+34.0%0.108%
10/21/2022Ingalls & Snyder LLC967,090$3.86M0.2%+2.9%3.878%
8/12/2022Ikarian Capital LLC61,433$237K0.0%-20.9%0.247%
8/11/2022Bank of Montreal Can194,164$801K0.0%+38.2%0.782%
8/10/2022Cibc World Market Inc.47,427$183K0.0%N/A0.191%
5/9/2022Ingalls & Snyder LLC932,200$4.79M0.2%+13.6%4.570%
2/11/2022Ingalls & Snyder LLC820,258$4.40M0.2%+32.0%4.215%
1/31/2022Gradient Capital Advisors LLC20,000$107K0.0%-7.9%0.103%
1/24/2022National Bank of Canada FI7,540$40K0.0%N/A0.039%
11/15/2021Marshall Wace LLP175,514$1.09M0.0%+384.1%0.906%
11/12/2021Trexquant Investment LP17,852$111K0.0%N/A0.092%
11/12/2021Credit Suisse AG88,829$553K0.0%+130.0%0.459%
10/27/2021Ingalls & Snyder LLC621,447$3.87M0.2%+3.4%3.212%
8/25/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188%
8/16/2021Credit Suisse AG38,623$233K0.0%+15.6%0.200%
8/16/2021Marshall Wace LLP36,259$218K0.0%+8.5%0.188%
8/13/2021Renaissance Technologies LLC17,400$105K0.0%N/A0.090%
8/13/2021AWM Investment Company Inc.398,145$2.40M0.2%-16.7%2.070%
8/12/2021Dimensional Fund Advisors LP12,538$75K0.0%N/A0.065%
8/12/2021JPMorgan Chase & Co.68,885$1.29M0.0%+55.4%0.358%
8/12/2021Bank of Montreal Can45,224$285K0.0%+543.8%0.235%
8/5/2021Orion Portfolio Solutions LLC14,111$85K0.0%-16.3%0.073%
8/3/2021Ingalls & Snyder LLC600,810$3.62M0.2%+16.2%3.124%
5/17/2021Ikarian Capital LLC150,000$1.47M0.0%N/A0.783%
5/14/2021Credit Suisse AG33,423$328K0.0%N/A0.174%
5/13/2021AWM Investment Company Inc.478,020$4.69M0.5%N/A2.494%
5/12/2021JPMorgan Chase & Co.44,320$435K0.0%+127.2%0.231%
5/11/2021Rockefeller Capital Management L.P.3,965$38K0.0%+75.4%0.021%
4/21/2021Ingalls & Snyder LLC517,195$5.08M0.2%+30.5%2.705%
2/19/2021JPMorgan Chase & Co.19,505$292K0.0%N/A0.116%
(Data available from 1/1/2016 forward)

IPA Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IPA shares?

During the previous two years, the following institutional investors and hedge funds held shares of ImmunoPrecise Antibodies shares: Ingalls & Snyder LLC ($996K), Bank of Montreal Can ($668K), and Renaissance Technologies LLC ($65K), Rathbones Group PLC ($26K).Learn more on IPA's institutional investors.

What percentage of ImmunoPrecise Antibodies stock is owned by institutional investors?

6.70% of ImmunoPrecise Antibodies stock is owned by institutional investors. Learn more on IPA's institutional investor holdings.

Which institutional investors have been buying ImmunoPrecise Antibodies stock?

The following institutional investors have purchased ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($604.39K), Bank of Montreal Can ($208.11K), Renaissance Technologies LLC ($26.31K), and Rathbones Group PLC ($14K).

How much institutional buying is happening at ImmunoPrecise Antibodies?

Institutional investors have bought a total of 852,811 shares in the last 24 months. This purchase volume represents approximately $1.51M in transactions.

Which ImmunoPrecise Antibodies major shareholders have been selling company stock?

The following institutional investors have sold ImmunoPrecise Antibodies stock in the last 24 months: Ingalls & Snyder LLC ($31.80K).

How much institutional selling is happening at ImmunoPrecise Antibodies?

Institutional investors have sold a total of 31,802 shares in the last 24 months. This volume of shares sold represents approximately $58.20K in transactions.



This page (NASDAQ:IPA) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners